Clinical trial

Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

NCT00004100

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record cisplatin Normalized identity: cisplatinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record gemcitabine hydrochloride Normalized identity: gemcitabine hydrochlorideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record vinorelbine tartrate Normalized identity: vinorelbine tartrateView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date1998-11-01

PhasePHASE3

Conditions

Lung Cancerverified · MONDO: lung cancer

Interventions

cisplatinDRUG · verified · RxNorm: cisplatin

gemcitabine hydrochlorideDRUG · verified · RxNorm: gemcitabine hydrochloride

vinorelbine tartrateDRUG · verified · RxNorm: vinorelbine tartrate

Sponsors & collaborators

Istituto Nazionale per lo Studio e la Cura dei Tumorilead sponsor

NCIC Clinical Trials Groupcollaborator

Mapped research locations

NaplesItaly5 MilanItaly3 RomeItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00004100 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.